DT
Dermata Therapeutics Inc
🇺🇸XNAS.DRMAUnited StatesHealthcare
$1.17USDup +0.04 (+3.54%)ClosedDelayed5:03 AM
Price$1.17+0.04 (+3.54%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US2498451085
- CUSIP
- 249845108
Company
- Employees
- 9
- Headquarters
- San Diego, United States
- Website
- https://www.dermatarx.com
- CEO
- Mr. Gerald T. Proehl
Market
- Shares outstanding
- 5M
- Market cap
- $5.8M
Highlights
- Market cap
- $5.8M
- EPS LTM
- -$2.08
- P/E LTM
- -0.63
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $00%unchanged year on year
- Net income
- -$8.37M+18.98%up year on year
- Gross margin
- Not reported
- Free cash flow
- -$8.14M+25.67%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.